Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01364363 · ClinicalTrials.gov registry record · NA
Unrelated Donor Stem Cell Transplantation
A NA study, sponsored by Scripps Health.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT01364363 is a NA study that has completed, run by Scripps Health. The registered enrollment target is 64 participants.
The verdict
NCT01364363, a NA study, has completed, sponsored by Scripps Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to provide an opportunity for patients with malignancies or bone marrow failure states who lack a suitable sibling donor to undergo allogeneic hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood registries.
Interventions
- PROCEDURE Allogeneic transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2005-03 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01364363
The ClinicalTrials.gov registry entry for NCT01364363 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Health, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Allogeneic transplantation is the first listed.
NCT01364363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01364363 about?
NCT01364363 is a clinical study titled "Unrelated Donor Stem Cell Transplantation". The purpose of this study is to provide an opportunity for patients with malignancies or bone marrow failure states who lack a suitable sibling donor to undergo allogeneic hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood registries.
What is the current status of trial NCT01364363?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2005-03. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01364363?
The interventions under investigation include: Allogeneic transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT01364363?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.